Added to YB: 2024-01-05
Pitch date: 2024-01-05
FIXX [bullish]
Homology Medicines, Inc.
+53.23%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of March 25, 2024, Homology Medicines, Inc. was acquired by Q32 Bio Inc., in a reverse merger transaction.
Market Cap
$54.3M
Pitch Price
$10.98
Price Target
1.38 (-92%)
Dividend
N/A
Sector
Biotechnology
Category
special_situation
Show full summary:
$FIXX: holding through 2024
FIXX reverse merging Q32 Bio at $1.38/sh vs $0.55 now. Holders get 25% NewCo ($0.50/sh cash), CVR for FIXX asset monetization (P1 IP+OXB JV w/5.5x TTM buyout). Hold thru merger for P2 readouts late '24, IR+CVR upside as Q32 must sell legacy assets.
Read full article (1 min)